These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 559555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A study of acquired inhibitors of factor IX by means of precipitating rabbit antisera against factor IX.
    Orstavik KH, Nilsson IM.
    Thromb Res; 1978 May; 12(5):863-74. PubMed ID: 97801
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An immunological method for detection of the carrier of hemophilia B.
    Matsuoka M, Ito M, Takahashi K, Sakuragawa N.
    Thromb Haemost; 1976 Nov 30; 36(2):441-50. PubMed ID: 1036844
    [Abstract] [Full Text] [Related]

  • 7. Relationship of factor IX antigen and coagulant in hemophilia B patients and carriers.
    Pechet L, Tiarks CY, Stevens J, Sudhindra RR, Lipworth L.
    Thromb Haemost; 1979 Feb 15; 40(3):465-77. PubMed ID: 425061
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM, Veltkamp JJ.
    Thromb Haemost; 1978 Oct 31; 40(2):335-49. PubMed ID: 734633
    [Abstract] [Full Text] [Related]

  • 10. Characterization of an occult inhibitor to factor IX in a haemophilia B patient.
    Miller CH, Orstavik KH, Hilgartner MW.
    Br J Haematol; 1985 Oct 31; 61(2):329-38. PubMed ID: 4041376
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Disappearance of inhibitor to factor IX in a patient with severe haemophilia B and immunological characterization of the inhibitor.
    Ohkubo Y, Takahashi Y, Sugimoto M, Nishino M, Nishimura T, Yoshioka A, Fukui H.
    Clin Lab Haematol; 1988 Oct 31; 10(2):177-85. PubMed ID: 2843318
    [Abstract] [Full Text] [Related]

  • 14. Detection of carriers of haemophilia B.
    Orstavik KH, Veltkamp JJ, Bertina RM, Hermans J.
    Br J Haematol; 1979 Jun 31; 42(2):293-301. PubMed ID: 465373
    [Abstract] [Full Text] [Related]

  • 15. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH.
    Br J Haematol; 1981 May 31; 48(1):15-23. PubMed ID: 6788066
    [Abstract] [Full Text] [Related]

  • 16. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR.
    J Clin Invest; 1977 May 31; 59(5):900-10. PubMed ID: 856873
    [Abstract] [Full Text] [Related]

  • 17. Laboratory prediction of the carrier state in hemophilia B: role of replication of assays.
    Lipworth L, Tiarks CY, Rice CA, Pechet L.
    Am J Clin Pathol; 1979 Dec 31; 72(6):1000-4. PubMed ID: 391020
    [Abstract] [Full Text] [Related]

  • 18. Detection of factor IX inhibitors by immunoradiometric assay.
    Ljung R, Holmberg L.
    Acta Haematol; 1983 Dec 31; 70(5):307-11. PubMed ID: 6414224
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.